Physician profile
Ellen Mellow
NPI 1366444259
$2,322.36
in general payments reported to CMS, 2019-2025
19 companies · $458 in 2025
The $458 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $663 · 2020: $78.60 · 2021: $90.02 · 2022: $56.31 · 2023: $399 · 2024: $578 · 2025: $458.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,435.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,434.53 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals Lp | $582.45 | 2019-2025 | Farxiga, Breztri, Lokelma |
| Amgen INC. | $476.08 | 2019-2025 | Repatha, Repatha |
| Novartis Pharmaceuticals Corporation | $333.31 | 2023-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $276.97 | 2019-2024 | Jardiance |
| Glaxosmithkline, LLC. | $221.79 | 2019-2025 | Trelegy Ellipta, Arexvy |
| Janssen Pharmaceuticals, INC | $68.12 | 2019-2024 | Xarelto |
| Merck Sharp & Dohme LLC | $61.07 | 2024 | Verquvo |
| Sanofi-Aventis U.S. LLC | $49.96 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $34.73 | 2019-2020 | |
| Medicomp INC | $31.81 | 2025 | Telepatch Cardiac Monitor |
| Kowa Pharmaceuticals America, INC. | $25.89 | 2019 | |
| Regeneron Healthcare Solutions, INC. | $24.15 | 2019 | |
| Edwards Lifesciences Corporation | $23.65 | 2023 | Sapien 3 Ultra Resilia |
| Novo Nordisk INC | $22.96 | 2020 | |
| Esperion Therapeutics, INC. | $21.60 | 2022 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $20.42 | 2023 | |
| Amarin Pharma, INC. | $17.78 | 2020 | |
| Senseonics, Incorporated | $16.00 | 2019 | |
| Lexicon Pharmaceuticals, INC. | $13.62 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ellen Mellow listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.